MD Anderson immunologist Jim Allison awarded Nobel Prize
Jim Allison, Ph.D., chair of Immunology and executive director of the Immunotherapy Platform at The University of Texas MD Anderson Cancer Center, has been awarded the 2018 Nobel Prize in Physiology or Medicine for launching an effective new way to attack cancer by treating the immune system rather than the tumor. Allison is the first MD Anderson scientist to receive the world’s most preeminent award for outstanding discoveries in the fields of life sciences and medicine.
The game changer
James Allison proved the human immune system could fight cancer, and his innovative work has earned him a lot of praise, including that of Facebook founder Mark Zuckerberg.
How does cancer immunotherapy work?
Traditionally, cancer treatment has revolved around chemotherapy, radiation and surgery. But thanks to groundbreaking immune checkpoint blockade research led by Jim Allison, Ph.D., winner of
Allison named one of TIME’s 100 most influential
MD Anderson Cancer Center Chair of Immunology Jim Allison, Ph.D., was named to the 2017 Time 100 list.
Jim Allison awarded Kovalenko medal
National Academy of Sciences awards Kovalenko medal to immunotherapy pioneer Jim Allison.
Celebrating immunotherapy’s pioneer
By finding a way to free the immune system to attack tumors, Allison invented immune checkpoint blockade, opening up an entirely new way to treat cancer.